Intelligence

#Artificial intelligence (AI)

Guide: How AI is transforming drug discovery

“How AI is transforming drug discovery” is an exclusive guide published by DDW that examines the challenges and opportunities this technology is presenting throughout the industry.   It features stories on how AI is shaping drug discovery, how RNA-targeted drug discovery is being pioneered by AI and how the technology… Read More

#DDW Guides

2026 ideas
#AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #Machine learning

2026: What will change in preclinical and clinical development?

How will preclinical discovery and clinical trials change in the coming year? And what role will regulators play? Diana Turner asks industry leaders for their predictions for 2026. A number of innovations are predicted to influence R&D in 2026, in both preclinical and clinical trials, including… Read More

#Exclusive Content #Trends & Analysis

2026 ideas
#AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #Machine learning

Drug discovery and development in 2026

Which drug modalities will dominate the market, and which global regions will be most influential? Diana Turner asks industry leaders for their predictions for 2026. The opportunities and challenges facing biotech and biopharma in 2026 are concisely summarised by Dr Kevin Land, Executive Medical Director Biotherapies… Read More

#Exclusive Content #Trends & Analysis

2026 ideas
#Advanced Therapies #Cell and gene therapy #Cell therapy #Drug discovery #Gene editing

CGT in 2026: In vivo, greater specificity and next-gen platforms

What does the coming year hold for advanced therapies? Diana Turner asks industry leaders for their predictions for 2026. 2025 was a mixed year for cell and gene therapies (CGT) with some incredible breakthroughs, but also a withdrawal of many companies from their cell therapy programmes. Read More

#Exclusive Content #Trends & Analysis

2026 ideas
#AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #Machine learning

2026: An AI tipping point for drug discovery

How big a role will AI play in the coming year? Diana Turner asks industry leaders for their predictions. As with all sectors, the role of artificial intelligence (AI) in drug discovery is expected to significantly increase in 2026 and beyond. Richard Young, CSO… Read More

#Exclusive Content #Trends & Analysis

#Drug discovery

Guide – Accelerate your imaging research with our updated protocols guide

This imaging protocol handbook will help you accelerate your research by helping you plan and execute your imaging experiments. The guide covers main procedural steps to achieve your best results. Plan and optimise imaging experiments with clear, step-by-step procedural guidance. Master core and advanced techniques—from cell proliferation and… Read More

#Guides

AI and genomics
#AI / data analytics / healthtech / informatics #Genetics / genomics #Genomics #Market reporting

How are innovations in genomics redefining drug discovery?

Advances in artificial intelligence and synthetic biology are driving a new frontier in genomic research. Megan Thomas explores what the future of genomics will look like. New technologies for the future In a Eureka! podcast interview with McKinsey, Howard Jacob, Vice President of Genomics Research… Read More

#Exclusive Content #Market Reports

#Biobanking #Biospecimen research #Drug discovery #eBook

Foundations of biospecimen success

Advances in biospecimen science are resolving long-standing challenges that have historically hindered research quality, reproducibility, and innovation across drug discovery, translational medicine, and biobanking. These gaps limit scientific progress because even the most sophisticated analytical tools depend on high-quality, well-characterised human biological specimens. This custom eBook from BioIVT explores the… Read More

#eBooks #Resources